Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

45.78 USD -3.20 (-6.53%)
Official Closing Price Updated: 7:59 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,846,200
Open 49.08
Bid (Size) 29.00 (3)
Ask (Size) 29.38 (1)
Prev. Close 48.98
Today's Range 45.71 - 49.23
52wk Range 30.02 - 58.72
Shares Outstanding 124,825,969
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Acadia Pharmaceuticals Provides Regulatory Update on Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company received a notification from the U.S. Food and Drug Administration (FDA) on March 3, 2021, stating that, as part of its... 
From Business Wire News Releases
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced financial results for the fourth quarter and full year ended December 31, 2020. 
From Business Wire News Releases

Performance

YTD
-13.31%
-13.31%
1 Month
-10.73%
-10.73%
3 Month
-14.24%
-14.24%
6 Month
+19.84%
+19.84%
1 Year
+16.43%
+16.43%

More News

Read More
Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
From Business Wire News Releases
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
From Business Wire News Releases
Noteworthy ETF Inflows: LABU, ALXO, ACAD, XLRN
Tags ETFs
From ETF Channel
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
From Business Wire News Releases
ROCE Insights For ACADIA Pharmaceuticals
Tags News Market News Earnings
From Benzinga
Recap: ACADIA Pharmaceuticals Q4 Earnings
Tags Market News Earnings ACAD
From Benzinga
Acadia Pharmaceuticals Announces Commercial Leadership Change
From Business Wire News Releases
Acadia Pharmaceuticals Crashes On FDA Setback For Psychosis Treatment
From Investor's Business Daily
A Preview Of ACADIA Pharmaceuticals's Earnings
Tags Market News BZI/EP Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.